Prenatal Exposure to Acid-Suppressive Medications and Incident Risk of Inflammatory Bowel Disease in Children - Quiz - MDSpire

Prenatal Exposure to Acid-Suppressive Medications and Incident Risk of Inflammatory Bowel Disease in Children

  • By

  • Jiyeon Oh

  • Jaeyu Park

  • Hyunjee Kim

  • Hyesu Jo

  • Kyeongmin Lee

  • Yeona Jo

  • Seohyun Hong

  • Sooji Lee

  • Selin Woo

  • Yerin Hwang

  • Jinseok Lee

  • Tae Hyeong Kim

  • Hayeon Lee

  • June 24, 2026

  • 0 min

Share

Original Source(s)

Prenatal Exposure to Acid-Suppressive Medications and Incident Risk of Inflammatory Bowel Disease in Children

  • by Jiyeon Oh, Jaeyu Park, Hyunjee Kim, Hyesu Jo, Kyeongmin Lee, Yeona Jo, Seohyun Hong, Sooji Lee, Selin Woo, Yerin Hwang, Jinseok Lee, Tae Hyeong Kim, Hayeon Lee

  • June 24, 2026

Related Content

Safety evaluation of subcutaneous and intravenous administration of infliximab: a real-world study based on the FAERS database

Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease

Cross-species systems analysis distinguishes inflammatory remodeling from primary mucus secretory failure in inflammatory bowel disease